{
  "experiment_id": "d6cea26cb5660ab7e875ea09e76488cd",
  "task_name": "narrowing_of_broad_synonyms",
  "task_hash": "9dc5c284f909400a12e111d9ec8ba4e5",
  "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
  "system_instructions": "### Temperature\n\n1.0",
  "temperature": 1.0,
  "thinking": false,
  "timestamp": "2025-11-13T19:26:39.200390",
  "task_result": {
    "task_name": "narrowing_of_broad_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis",
          "assay": "DNA sequencing",
          "tumorType": "Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"Neurofibromatosis\" \u2192 \"Neurofibromatosis type 1\"\n   - The broad term \"Neurofibromatosis\" has been narrowed to the more specific \"Neurofibromatosis type 1\", which is the most common form and the primary controlled terminology available in the schema.\n\n2. **assay**: \"DNA sequencing\" \u2192 \"whole genome sequencing\"\n   - The broad term \"DNA sequencing\" has been replaced with \"whole genome sequencing\", a more specific sequencing method that matches the controlled terminology in the schema.\n\n3. **tumorType**: \"Neurofibroma\" \n   - This value already matches the controlled terminology exactly, so no change was needed.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2993,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 227
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_012zLGud8DTqGxETTkiCFx6t",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"Neurofibromatosis\" \u2192 \"Neurofibromatosis type 1\"\n   - The broad term \"Neurofibromatosis\" has been narrowed to the more specific \"Neurofibromatosis type 1\", which is the most common form and the primary controlled terminology available in the schema.\n\n2. **assay**: \"DNA sequencing\" \u2192 \"whole genome sequencing\"\n   - The broad term \"DNA sequencing\" has been replaced with \"whole genome sequencing\", a more specific sequencing method that matches the controlled terminology in the schema.\n\n3. **tumorType**: \"Neurofibroma\" \n   - This value already matches the controlled terminology exactly, so no change was needed."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2993,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 227
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2993,
          "output_tokens": 227,
          "total_tokens": 3220
        }
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "NF",
          "assay": "exome sequencing",
          "tumorType": "sarcoma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n```\n\n**Changes made:**\n- **diagnosis**: \"NF\" \u2192 \"Neurofibromatosis type 1\" (narrowed from broad abbreviation to specific diagnosis)\n- **assay**: \"exome sequencing\" \u2192 \"whole exome sequencing\" (matched to exact controlled terminology)\n- **tumorType**: \"sarcoma\" \u2192 \"Sarcoma\" (capitalized to match exact controlled terminology value)",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2987,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 148
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01D8tSn7HpMzyEXAFoDafBdR",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n```\n\n**Changes made:**\n- **diagnosis**: \"NF\" \u2192 \"Neurofibromatosis type 1\" (narrowed from broad abbreviation to specific diagnosis)\n- **assay**: \"exome sequencing\" \u2192 \"whole exome sequencing\" (matched to exact controlled terminology)\n- **tumorType**: \"sarcoma\" \u2192 \"Sarcoma\" (capitalized to match exact controlled terminology value)"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2987,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 148
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2987,
          "output_tokens": 148,
          "total_tokens": 3135
        }
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Neurofibromatoses",
          "assay": "assay by high throughput sequencer",
          "tumorType": "Nerve Sheath Neoplasm"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"Neurofibromatoses\" \u2192 \"Neurofibromatosis type 1\" (narrowed from the broad plural form to the specific controlled terminology value)\n\n2. **assay**: \"assay by high throughput sequencer\" \u2192 \"whole genome sequencing\" (narrowed from the generic description to a specific sequencing method from the controlled vocabulary)\n\n3. **tumorType**: \"Nerve Sheath Neoplasm\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\" (narrowed from the broad general term to the specific controlled terminology value that represents a nerve sheath tumor classification)",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3002,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 211
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_015DL5XteDP8T6pckbk8Hd5Y",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"Neurofibromatoses\" \u2192 \"Neurofibromatosis type 1\" (narrowed from the broad plural form to the specific controlled terminology value)\n\n2. **assay**: \"assay by high throughput sequencer\" \u2192 \"whole genome sequencing\" (narrowed from the generic description to a specific sequencing method from the controlled vocabulary)\n\n3. **tumorType**: \"Nerve Sheath Neoplasm\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\" (narrowed from the broad general term to the specific controlled terminology value that represents a nerve sheath tumor classification)"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3002,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 211
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3002,
          "output_tokens": 211,
          "total_tokens": 3213
        }
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurocutaneous syndrome",
          "assay": "spectroscopy",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"neurocutaneous syndrome\" \u2192 \"Unknown\" \n   - \"Neurocutaneous syndrome\" is a broad category that doesn't match any specific controlled term in the schema. The most appropriate mapping is \"Unknown\" since the specific diagnosis cannot be determined from the general term provided.\n\n2. **assay**: \"spectroscopy\" \u2192 \"FTIR spectroscopy\"\n   - \"Spectroscopy\" is too broad. \"FTIR spectroscopy\" is the most commonly used spectroscopy method in the controlled terminology for biological/molecular research contexts.\n\n3. **tumorType**: \"unknown\" \u2192 \"Unknown\"\n   - Capitalized to match the exact controlled terminology value in the schema (enum values are case-sensitive).",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2987,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 216
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01MNv3i4xDUEU6aWCVxtrWpz",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"neurocutaneous syndrome\" \u2192 \"Unknown\" \n   - \"Neurocutaneous syndrome\" is a broad category that doesn't match any specific controlled term in the schema. The most appropriate mapping is \"Unknown\" since the specific diagnosis cannot be determined from the general term provided.\n\n2. **assay**: \"spectroscopy\" \u2192 \"FTIR spectroscopy\"\n   - \"Spectroscopy\" is too broad. \"FTIR spectroscopy\" is the most commonly used spectroscopy method in the controlled terminology for biological/molecular research contexts.\n\n3. **tumorType**: \"unknown\" \u2192 \"Unknown\"\n   - Capitalized to match the exact controlled terminology value in the schema (enum values are case-sensitive)."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2987,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 216
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2987,
          "output_tokens": 216,
          "total_tokens": 3203
        }
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunoassay",
          "tumorType": "neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Changes made:**\n- `tumorType`: \"neurofibroma\" \u2192 \"Neurofibroma\" (corrected to match exact controlled terminology with proper capitalization)",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2989,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 86
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_017Xn2vTckQpPZpCCVHZ6nVr",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Changes made:**\n- `tumorType`: \"neurofibroma\" \u2192 \"Neurofibroma\" (corrected to match exact controlled terminology with proper capitalization)"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2989,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 86
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2989,
          "output_tokens": 86,
          "total_tokens": 3075
        }
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "neurofibromatosis",
          "assay": "plate based reporter assay",
          "tumorType": "benign neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"massively parallel reporter assay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"neurofibromatosis\" \u2192 \"Neurofibromatosis type 1\" - The broad term \"neurofibromatosis\" has been narrowed to the specific type most commonly referenced in the schema.\n\n2. **assay**: \"plate based reporter assay\" \u2192 \"massively parallel reporter assay\" - The generic \"plate based reporter assay\" has been replaced with the more specific controlled term from the schema.\n\n3. **tumorType**: \"benign neurofibroma\" \u2192 \"Neurofibroma\" - The descriptor \"benign\" has been removed as the schema uses the precise term \"Neurofibroma\" without qualifiers. The schema entry \"Neurofibroma\" encompasses the benign classification.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2995,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 229
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01GRYbtZEKxHHkCk9tCfn5KA",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"massively parallel reporter assay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"neurofibromatosis\" \u2192 \"Neurofibromatosis type 1\" - The broad term \"neurofibromatosis\" has been narrowed to the specific type most commonly referenced in the schema.\n\n2. **assay**: \"plate based reporter assay\" \u2192 \"massively parallel reporter assay\" - The generic \"plate based reporter assay\" has been replaced with the more specific controlled term from the schema.\n\n3. **tumorType**: \"benign neurofibroma\" \u2192 \"Neurofibroma\" - The descriptor \"benign\" has been removed as the schema uses the precise term \"Neurofibroma\" without qualifiers. The schema entry \"Neurofibroma\" encompasses the benign classification."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2995,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 229
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2995,
          "output_tokens": 229,
          "total_tokens": 3224
        }
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "RASopathy",
          "assay": "immunoassay",
          "tumorType": "NFIB"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"RASopathy\" \u2192 \"Noonan Syndrome\" - RASopathies are a group of genetic syndromes caused by mutations in genes encoding proteins in the RAS/MAPK pathway. Noonan Syndrome is the most common RASopathy and is the specific controlled terminology available in the schema.\n\n2. **assay**: \"immunoassay\" - No change needed; this exact value exists in the controlled terminology.\n\n3. **tumorType**: \"NFIB\" \u2192 \"Neurofibroma\" - \"NFIB\" is an abbreviation for a type of neurofibroma. The schema uses the full term \"Neurofibroma\" as the controlled terminology.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2990,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 220
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01R8Qz7E4x1K2Y5RSeaxc4zb",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"RASopathy\" \u2192 \"Noonan Syndrome\" - RASopathies are a group of genetic syndromes caused by mutations in genes encoding proteins in the RAS/MAPK pathway. Noonan Syndrome is the most common RASopathy and is the specific controlled terminology available in the schema.\n\n2. **assay**: \"immunoassay\" - No change needed; this exact value exists in the controlled terminology.\n\n3. **tumorType**: \"NFIB\" \u2192 \"Neurofibroma\" - \"NFIB\" is an abbreviation for a type of neurofibroma. The schema uses the full term \"Neurofibroma\" as the controlled terminology."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2990,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 220
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2990,
          "output_tokens": 220,
          "total_tokens": 3210
        }
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "NF",
          "assay": "medical imaging",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"NF\" \u2192 \"Neurofibromatosis type 1\" (narrowed from the broad abbreviation to the specific controlled terminology)\n\n2. **assay**: \"medical imaging\" \u2192 \"conventional MRI\" (narrowed from the broad category to a specific imaging modality commonly used in neurofibromatosis diagnostics)\n\n3. **tumorType**: \"unknown\" \u2192 \"Unknown\" (standardized capitalization to match the exact controlled terminology value)",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2983,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 162
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_011uYioQzp1RYyzsHVer6vcE",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"NF\" \u2192 \"Neurofibromatosis type 1\" (narrowed from the broad abbreviation to the specific controlled terminology)\n\n2. **assay**: \"medical imaging\" \u2192 \"conventional MRI\" (narrowed from the broad category to a specific imaging modality commonly used in neurofibromatosis diagnostics)\n\n3. **tumorType**: \"unknown\" \u2192 \"Unknown\" (standardized capitalization to match the exact controlled terminology value)"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2983,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 162
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2983,
          "output_tokens": 162,
          "total_tokens": 3145
        }
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "neurocristopathy",
          "assay": "transcriptomics",
          "tumorType": "neurolemmoma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"transcriptomics\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of changes:**\n\n1. **diagnosis**: \"neurocristopathy\" is a broad, general term referring to a group of neural crest-derived disorders. Since it doesn't match any specific enum value in the controlled terminology and lacks sufficient specificity for this schema, it has been changed to \"Unknown\".\n\n2. **assay**: \"transcriptomics\" already matches an exact controlled terminology value, so no change was needed.\n\n3. **tumorType**: \"neurolemmoma\" is a synonym for schwannoma (a tumor arising from the nerve sheath/Schwann cells). The precise controlled terminology equivalent is \"Schwannoma\".",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2991,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 187
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01GuWcpPnEJfKtxFCuiTUPFq",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"transcriptomics\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of changes:**\n\n1. **diagnosis**: \"neurocristopathy\" is a broad, general term referring to a group of neural crest-derived disorders. Since it doesn't match any specific enum value in the controlled terminology and lacks sufficient specificity for this schema, it has been changed to \"Unknown\".\n\n2. **assay**: \"transcriptomics\" already matches an exact controlled terminology value, so no change was needed.\n\n3. **tumorType**: \"neurolemmoma\" is a synonym for schwannoma (a tumor arising from the nerve sheath/Schwann cells). The precise controlled terminology equivalent is \"Schwannoma\"."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2991,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 187
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 2991,
          "output_tokens": 187,
          "total_tokens": 3178
        }
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "phakomatosis",
          "assay": "viability assay",
          "tumorType": "tumor of cranial and spinal nerves"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"phakomatosis\" is a broad term for hereditary hamartoma syndromes. Given the context of the other fields (schwannoma-related tumor type), this has been narrowed to \"Unknown\" since the specific diagnosis cannot be reliably determined from the broad term alone. If more context were available, this could potentially map to \"Neurofibromatosis type 1\" or a schwannomatosis variant.\n\n2. **assay**: \"viability assay\" is broad and non-specific. The controlled terminology specifies \"cell viability assay\" as the precise term for assessing cell survival/viability.\n\n3. **tumorType**: \"tumor of cranial and spinal nerves\" is a broad anatomical classification. This has been narrowed to \"Schwannoma\", which is the specific nerve sheath tumor type that aligns with the diagnosis context and is the most common tumor of this anatomical category.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2995,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 260
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01Hxb2SQd5s3H7Gbb34Cay6E",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"phakomatosis\" is a broad term for hereditary hamartoma syndromes. Given the context of the other fields (schwannoma-related tumor type), this has been narrowed to \"Unknown\" since the specific diagnosis cannot be reliably determined from the broad term alone. If more context were available, this could potentially map to \"Neurofibromatosis type 1\" or a schwannomatosis variant.\n\n2. **assay**: \"viability assay\" is broad and non-specific. The controlled terminology specifies \"cell viability assay\" as the precise term for assessing cell survival/viability.\n\n3. **tumorType**: \"tumor of cranial and spinal nerves\" is a broad anatomical classification. This has been narrowed to \"Schwannoma\", which is the specific nerve sheath tumor type that aligns with the diagnosis context and is the most common tumor of this anatomical category."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2995,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 260
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2995,
          "output_tokens": 260,
          "total_tokens": 3255
        }
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.4,
      "min_score": 0.0,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 29.94742202758789,
    "token_usage": {
      "input_tokens": 29912,
      "output_tokens": 1946,
      "total_tokens": 31858
    }
  }
}